GlassScriptPhysician profile
Katherine B Noble
NPI 1356394787
$8,728.70
in general payments reported to CMS, 2019-2025
41 companies · $201 in 2025
The $201 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,798 · 2022: $2,197 · 2023: $2,390 · 2024: $2,144 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,734.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,029.15 | 2021-2025 | |
| Novo Nordisk INC | $918.62 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $841.34 | 2021-2024 | |
| Lilly USA, LLC | $684.00 | 2021-2024 | Mounjaro, Zepbound, Jardiance |
| Novartis Pharmaceuticals Corporation | $603.47 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $506.15 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $484.85 | 2021-2024 | Breztri, Farxiga, Airsupra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $458.06 | 2021-2025 | Xifaxan |
| Amgen INC. | $378.06 | 2021-2025 | Repatha, Otezla, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $332.86 | 2021-2023 | Jardiance |
| Horizon Therapeutics Plc | $229.75 | 2021-2022 | |
| Astellas Pharma US INC | $205.68 | 2021-2023 | Myrbetriq |
| Kowa Pharmaceuticals America, INC. | $203.50 | 2021-2023 | Livalo, Seglentis |
| Takeda Pharmaceuticals U.S.A., INC. | $199.39 | 2021-2023 | Trintellix |
| Biohaven Pharmaceuticals, INC. | $197.49 | 2021 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Noble listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.